Display options
Cite
Zendelovska D, Simeska S, Atanasovska E, et al. Determination of Acyclovir in Human Plasma Samples by HPLC Method with UV Detection: Application to Single-Dose Pharmacokinetic Study. Open Access Maced J Med Sci. 2015;3(1):32-6doi: 10.3889/oamjms.2015.011.
Zendelovska, D., Simeska, S., Atanasovska, E., Georgievska, K., Kikerkov, I., Labachevski, N., Jakovski, K., & Balkanov, T. (2015). Determination of Acyclovir in Human Plasma Samples by HPLC Method with UV Detection: Application to Single-Dose Pharmacokinetic Study. Open access Macedonian journal of medical sciences, 3(1), 32-6. https://doi.org/10.3889/oamjms.2015.011
Zendelovska, Dragica, et al. "Determination of Acyclovir in Human Plasma Samples by HPLC Method with UV Detection: Application to Single-Dose Pharmacokinetic Study." Open access Macedonian journal of medical sciences vol. 3,1 (2015): 32-6. doi: https://doi.org/10.3889/oamjms.2015.011
Zendelovska D, Simeska S, Atanasovska E, Georgievska K, Kikerkov I, Labachevski N, Jakovski K, Balkanov T. Determination of Acyclovir in Human Plasma Samples by HPLC Method with UV Detection: Application to Single-Dose Pharmacokinetic Study. Open Access Maced J Med Sci. 2015 Mar 15;3(1):32-6. doi: 10.3889/oamjms.2015.011. Epub 2015 Jan 22. PMID: 27275193; PMCID: PMC4877785.
Copy Download .nbib Format: NLM
Share it on

Open Access Maced J Med Sci. 2015 Mar 15;3(1):32-6. doi: 10.3889/oamjms.2015.011. Epub 2015 Jan 22.

Determination of Acyclovir in Human Plasma Samples by HPLC Method with UV Detection: Application to Single-Dose Pharmacokinetic Study.

Open access Macedonian journal of medical sciences

Dragica Zendelovska, Suzana Simeska, Emilija Atanasovska, Kalina Georgievska, Igor Kikerkov, Nikola Labachevski, Krume Jakovski, Trajan Balkanov

Affiliations

  1. Institute of Preclinical and Clinical Pharmacology and Toxicology, Medical Faculty, Ss. Cyril and Methodius University of Skopje, 50 Divizija 16, 1109 Skopje, Republic of Macedonia.

PMID: 27275193 PMCID: PMC4877785 DOI: 10.3889/oamjms.2015.011

Abstract

BACKGROUND: The aim of this study is estimation of pharmacokinetic parameters: Cmax, tmax, t1/2, AUC0-t and AUC0-∞ with the two-way analysis of variance, single observation (ANOVA) for two preparations containing acyclovir.

OBJECTIVE: In order to evaluate pharmacokinetic study of acyclovir, method for quantitative determination of acyclovir in human plasma should be simple, rapid and reproducible. Therefore, the method is developed, validated and applied for analysis of acyclovir in plasma samples obtained from healthy volunteers.

MATERIAL AND METHODS: High performance liquid chromatographic (HPLC) method with UV-detection for the determination of acyclovir in human plasma is presented. This method involves protein precipitation with 20 % (V/V) perchloric acid. The chromatographic separation was accomplished on a reversed phase C8 column with a mobile phase composed of 0.1 % (V/V) triethylamine in water (pH 2.5). No internal standard is required. UV detection was set at 255 nm. The method was successfully applied for the evaluation of pharmacokinetic profiles of acyclovir tablets in 24 healthy volunteers.

RESULTS: The validation results shows that proposed method is rugged, precise (RSDs for intra- and inter-day precision ranged from 1.02 to 8.37 %) and accurate (relative errors are less than 6.66 %). The calibration curve was linear in the concentration range of 0.1-2.0 µg/ml and the limit of quantification was 0.1 µg/ml. The Cmax, tmax and AUCs for the two products were not statistically different (p>0.05), suggesting that the plasma profiles generated by Zovirax were comparable to those produced by acyclovir manufactured by Jaka 80 company.

CONCLUSION: Good precision, accuracy, simplicity, sensitivity and shorter time of analysis of the method makes it particularly useful for processing of multiple samples in a limited period of time for pharmacokinetic study of acyclovir.

Keywords: HPLC; Zovirax; acyclovir; human plasma; pharmacokinetic study

References

  1. Biomed Chromatogr. 2003 Dec;17(8):500-3 - PubMed
  2. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 25;780(2):289-94 - PubMed
  3. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 May 15;867(2):270-6 - PubMed
  4. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 5;772(2):327-34 - PubMed
  5. J AOAC Int. 2010 Sep-Oct;93(5):1462-7 - PubMed
  6. Biomed Chromatogr. 2008 Aug;22(8):879-87 - PubMed
  7. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 5;772(2):291-7 - PubMed
  8. Biomed Chromatogr. 2009 Aug;23(8):822-7 - PubMed
  9. J Chromatogr B Biomed Sci Appl. 2000 Mar 10;739(2):231-7 - PubMed
  10. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):420-9 - PubMed
  11. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 25;816(1-2):327-31 - PubMed
  12. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 5;791(1-2):357-63 - PubMed

Publication Types